Changes in Notch4 are of particular interest because previous studies have shown that blocking NOTCH4 receptor activity inhibits tumor formation of xenografted breast cancer cells, whereas blocking NOTCH1 has less of an effect [72]. This evidence concerns the gene NOTCH4 and breast carcinoma.